FDA Drug Application (021925) for DUETACT by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number021925
Product Number001
FormTABLET;ORAL
Dosage2MG;30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDUETACT
Active IngredientGLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient GLIMEPIRIDE6
List of drugs with Active Ingredient PIOGLITAZONE HYDROCHLORIDE9


Back to FDA Applications sponsored by TAKEDA PHARMS USA